Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Caron G, Ermondi G.
J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm048980b PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för (S)-timolol (anhydrous). Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
20 träffarSurface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Suomalainen P, Johans C, Söderlund T, Kinnunen PK.
J Med Chem · journal article · DOI 10.1021/jm0309001Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Lombardo F, Obach RS, Shalaeva MY, Gao F.
J Med Chem · journal article · DOI 10.1021/jm030408hGraphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates.
Mandagere AK, Thompson TN, Hwang KK.
J Med Chem · journal article · DOI 10.1021/jm010152kCheminformatic models to predict binding affinities to human serum albumin.
Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL.
J Med Chem · journal article · DOI 10.1021/jm010960bHigh-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes.
Wohnsland F, Faller B.
J Med Chem · journal article · DOI 10.1021/jm001020eQSAR model for drug human oral bioavailability.
Yoshida F, Topliss JG.
J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm0000564New approaches to antiglaucoma therapy.
Sugrue MF.
J Med Chem · review; journal article · DOI 10.1021/jm9608725Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Gaillard P, Carrupt PA, Testa B, Schambel P.
J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm950410bAcetazolamide-like carbonic anhydrase inhibitors with topical ocular hypotensive activity.
Antonaroli S, Bianco A, Brufani M, Cellai L, Lo Baido G, Potier E, Bonomi L, Perfetti S, Fiaschi AI, Segre G.
J Med Chem · journal article · DOI 10.1021/jm00092a021Reevaluating equilibrium and kinetic binding parameters for lipophilic drugs based on a structural model for drug interaction with biological membranes.
Mason RP, Rhodes DG, Herbette LG.
J Med Chem · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; review; journal article · DOI 10.1021/jm00107a001Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
el Tayar N, Carrupt PA, Van de Waterbeemd H, Testa B.
J Med Chem · research support, non-u.s. gov't; review; journal article · DOI 10.1021/jm00119a004(Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: increased permeation through biological membranes.
Alexander J, Cargill R, Michelson SR, Schwam H.
J Med Chem · journal article · DOI 10.1021/jm00397a008Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2.
Baldwin JJ, Christy ME, Denny GH, Habecker CN, Freedman MB, Lyle PA, Ponticello GS, Varga SL, Gross DM, Sweet CS.
J Med Chem · journal article · DOI 10.1021/jm00156a028[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
McNeal ET, Lewandowski GA, Daly JW, Creveling CR.
J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm00381a019Functional group contributions to drug-receptor interactions.
Andrews PR, Craik DJ, Martin JL.
J Med Chem · comparative study; journal article · DOI 10.1021/jm00378a021Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted-amino)-2-hydroxypropoxy]phenyl]imidazole class.
Baldwin JJ, Denny GH, Hirschmann R, Freedman MB, Ponticello GS, Gross DM, Sweet CS.
J Med Chem · comparative study; journal article · DOI 10.1021/jm00361a004Use of (S)-(trifloxymethyl)oxirane in the synthesis of a chiral beta-adrenoceptor antagonist, (R)- and (S)-9-[[3-(tert-butylamino)-2-hydroxypropyl]oximino]fluorene.
Baldwin JJ, McClure DE, Gross DM, Williams M.
J Med Chem · journal article · DOI 10.1021/jm00350a009Approaches to vasodilating/beta-adrenergic blocking agents: examples of the dihydrolutidine type.
Baldwin JJ, Hirschmann R, Engelhardt EL, Ponticello GS, Sweet CS, Scriabine A.
J Med Chem · journal article · DOI 10.1021/jm00137a028Urinary metabolites of timolol from humans and laboratory animals. Syntheses and beta-adrenergic blocking activities.
Wasson BK, Scheigetz J, Rooney CS, Hall RA, Share NN, VandenHeuvel WJ, Arison BH, Hensens OD, Ellsworth RL, Tocco DJ.
J Med Chem · journal article · DOI 10.1021/jm00185a006